Press Releases

Press Releases

  1. BTG plc: Directorate change

  2. BTG plc: close period update

  3. BTG Announces Replacement Policy for Expired CroFab®

  4. BTG announces global launch of the ICEfx™ Cryoablation System

  5. FDA Approves CroFab® Product Improvements

  6. BTG plc acquires Novate Medical Ltd.

  7. BTG receives not-approvable letter from the US FDA for ELEVAIR™

  8. OPTALYSE PE Results Published in JACC: Cardiovascular Interventions

  9. BTG plc: Annual General Meeting

  10. PERT Consortium and BTG Form Strategic Partnership

  11. Historical Financial Information Restated to US Dollars

  12. Result of FDA Advisory Committee vote on Elevair™ for the treatment of severe emphysema

  13. ELEVATE study aims to improve selection criteria and outcomes for patients with severe emphysema treated with the PneumRx™ Endobronchial Coil System

  14. BTG plc: Final Results 2018

  15. OPTALYSE PE Results Presented at Society for Cardiovascular Angiography and Interventions

  16. BTG plc: close period update

  17. SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program

  18. OPTALYSE PE Long Term Results Reinforce Safety and Efficacy of Shorter, Lower Dose EKOS® Therapy For Pulmonary Embolism

  19. Appointment of Non-executive Director